Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Royalindo Investa Wijaya Tbk. (INDO) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Royalindo Investa Wijaya Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Royalindo Investa Wijaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Royalindo Investa Wijaya Tbk. trades at Rp176 (market cap 788.61B, 21.91M 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is far larger — about 2.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (21.91M versus 41.7K). Which is the better fit depends on your goals.

DGNSINDO
Market Cap
316.25B788.61B
Volume
41.7K21.91M
Lot
417219.11K
Turnover
9.66M3.83B
Average Price
231.65174.83
Value
9.66M3.83B
Indicative Equilibrium Price
230176
Indicative Equilibrium Volume
2.4K114

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
INDO
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Royalindo Investa Wijaya Tbk.

PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.

Read more on INDO